SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-049936
Filing Date
2024-04-29
Accepted
2024-04-29 16:30:53
Documents
130
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 20-F sva-20231231.htm   iXBRL 20-F 4668286
2 EX-8.1 sva-ex8_1.htm EX-8.1 13509
3 EX-12.1 sva-ex12_1.htm EX-12.1 12338
4 EX-12.2 sva-ex12_2.htm EX-12.2 12332
5 EX-13.1 sva-ex13_1.htm EX-13.1 6196
6 EX-13.2 sva-ex13_2.htm EX-13.2 6173
7 EX-15.1 sva-ex15_1.htm EX-15.1 5096
8 EX-97.1 sva-ex97_1.htm EX-97.1 39065
9 GRAPHIC img57734221_0.jpg GRAPHIC 37473
10 GRAPHIC img57734221_1.jpg GRAPHIC 192836
  Complete submission text file 0000950170-24-049936.txt   18340779

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sva-20231231.xsd EX-101.SCH 2263217
134 EXTRACTED XBRL INSTANCE DOCUMENT sva-20231231_htm.xml XML 3343059
Mailing Address NO. 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085
Business Address NO. 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085 86-10-82890088
SINOVAC BIOTECH LTD (Filer) CIK: 0001084201 (see all company filings)

IRS No.: 000000000 | State of Incorp.: B9 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-32371 | Film No.: 24891488
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)